The influence of hypovitaminosis D on iron deficiency in healthy wome

Completed

• Conditions: Hypovitaminosis D and iron deficiency; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN18154581
• Lead Sponsor: Instituto De Medicina Integral Professor Fernando Figueira

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-10-09
• Last Update Posted: 30 October 2017

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 3667

Inclusion Criteria

1. Women older than 18 years old
2. Who did not have chronic diseases
3. In whom the results of 25-hydroxyvitamin D (25OHD)
4. Soluble transferrin receptor (sTfR)
5. Ferritin levels available
6. Chronic diseases as defined as the following a self-report of cancer, heart failure, pulmonary emphysema, chronic bronchitis, gastric or intestinal diseases; changes in laboratory markers of liver disease (aspartate aminotransferase greater than 121 U/L, alanine aminotransferase greater than 128 U/L and total bilirubin greater than 2.1 mg/dL) or renal disease (creatinine greater than 1.5 mg/dL); and the presence of a HIV-positive serology.

Exclusion Criteria

1. Women who reported undergoing iron supplementation in the last 3 months
2. Who had a positive pregnancy test or changes in the markers of malnutrition (albumin < 3.5 g/dL)
3. Inflammation (C-reactive protein (CRP) > 5.0 mg/dL) or iron overload (transferrin saturation > 45%)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vitamin D levels in correlation with body iron stores (BIS) are measured using patient data and a predictive model.

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures.<br>